Acute Myelogenous Leukemia (AML)

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Acute Myelogenous Leukemia Facts

Acute myelogenous leukemia (AML) is an aggressive form of blood cancer in which too many normal myeloid blood stem cells become abnormal leukemic cells. Other names for this disease are acute myeloid leukemia, acute myeloblastic leukemia, acute granulocytic leukemia and acute nonlymphocytic leukemia. The term “acute” means that this disease progresses quickly, and if it is not treated, it can be fatal within a few months.

This disease typically affects older people. The average age at diagnosis is 67 years old, although about 25 to 30 percent of patients are younger than age 50. According to the American Cancer Society, of the estimated 44,000 cases of leukemia diagnosed in 2008, approximately 13,000 were AML.


What Is Leukemia?

An overview about leukemia in general and acute myelogenous leukemia in particular.

Diagnosing AML

Here’s how your doctor will test for and diagnose AML.

Classifying AML

Learn about the two ways doctors classify AML.

Symptoms and Risk Factors

Learn about the symptoms and risk factors associated with AML.